title: Zero deaths from tuberculosis: progress, reality, and hope.
authors.affiliation: Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK. a.zumla@ucl.ac.uk
authors.forename: Alimuddin
authors.initials: A
authors.lastname: Zumla
authors.forename: Peter
authors.initials: P
authors.lastname: Kim
authors.forename: Markus
authors.initials: M
authors.lastname: Maeurer
authors.forename: Marco
authors.initials: M
authors.lastname: Schito
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000382:microbiology; D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use; D003141:Communicable Diseases; D006291:Health Policy; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D019095:Point-of-Care Systems; D012293:Rifampin; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D032581:Tuberculosis Vaccines / Q000008:administration & dosage; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D000995:Antitubercular Agents; D032581:Tuberculosis Vaccines; D012293:Rifampin